Neanderthal Gene Variant Boosts Muscle Mass in Modern Humans
- Neanderthal receptor boosts muscle cell growth by 40%
- Up to 24% of South Asians carry the variant
- Carriers have 270g more muscle mass on average
- Variant rare in Europeans at 0.5%
- Effects become noticeable after puberty
A genetic legacy left by extinct Neanderthals gives some modern humans a distinct biological advantage in muscle mass. Researchers found that a specific version of the growth hormone receptor (GHR), inherited from Neanderthals, increases muscle growth in laboratory cells by 40% (according to official data). This variant contributes to roughly 270 grams of additional muscle mass in carriers compared to those without it. The study, published in the journal Current Biology, highlights how ancient interbreeding continues to shape human physiology today. An international team led by Hugo Zeberg of the Karolinska Institutet and Philipp Kanis of the Max Planck Institute for Evolutionary Anthropology uncovered the link after analyzing the genomes of about 5,000 modern individuals. The findings provide concrete evidence that archaic genes are not just silent passengers but active drivers of physical traits. This discovery sheds light on why some populations might have different propensities for muscle building. The research focused on the growth hormone receptor, a critical protein on the surface of cells that binds to growth hormone. This binding triggers cellular growth and metabolism. The Neanderthal version of this receptor works differently than the standard modern human version. It is more sensitive to the hormone, effectively turning up the volume on the body's signal to build muscle. This small genetic tweak has measurable effects that persist in the gene pool today. "This shows that the genetic contribution from Neanderthals has functional consequences for people today," Zeberg said. The study is one of the first to pinpoint a specific anatomical difference caused by Neanderthal DNA. While many Neanderthal variants are associated with disease or immune response, this one directly affects body composition. It offers a window into the biology of our closest evolutionary relatives and how they adapted to their environments. The implications extend beyond mere curiosity about human evolution. Understanding how this receptor functions could inform treatments for muscle wasting diseases. It also helps explain the natural variation in body strength and size seen across different human populations. The presence of this variant is a reminder that the human genome is a mosaic of different hominin lineages, pieced together through millennia of migration and interaction. Most non-African humans carry approximately 1-2% Neanderthal DNA, but this study identifies a specific instance where that archaic inheritance provides a tangible, quantifiable physical benefit rather than a susceptibility to disease.
South Asian Populations Carry Strongest Ancient Genetic Link
The distribution of this muscle-boosting gene is not uniform across the globe. It is surprisingly common in South and East Asia but virtually absent in Europe. Up to 24% of people in some South Asian populations carry the Neanderthal variant, reaching as high as 28% in certain Pakistani cohorts (industry reports indicate). In stark contrast, only about 0.5% of Europeans possess this specific genetic marker, based on a sample of 2,000 genomes. This uneven distribution tells a complex story of ancient migrations, random chance, and environmental pressures. Modern humans inherited this variant through interbreeding with Neanderthals roughly 47,000 years ago. This mixing occurred after early humans migrated out of Africa and into Eurasia, where Neanderthals had lived for hundreds of thousands of years. As the ancestors of modern Europeans and Asians diverged, they carried different sets of these archaic genes. The high frequency in Asia suggests the variant may have provided a survival advantage in those regions, or it may simply be a result of the specific genetic bottlenecks those populations experienced. "The variant is particularly common in South and East Asia," Kanis noted. Researchers are still investigating why the variant persisted at such high rates in these populations while fading away in others. One theory involves genetic drift, where random changes in gene frequencies over generations cause some variants to disappear and others to dominate. Another theory suggests natural selection favored the trait in certain environments, perhaps where a robust physique was necessary for survival or where dietary conditions made higher muscle mass advantageous. The climate of Eurasia during the Pleistocene era was harsh and cold. Neanderthals evolved a stocky, powerful build to retain heat and survive in Ice Age conditions. A genetic predisposition to higher muscle mass would have been beneficial for anyone living in those challenging environments. As modern humans moved into these territories, acquiring Neanderthal genes through mating could have helped them adapt quickly to the glacial climates of the north. The near absence of the variant in Europe remains a puzzle. It is possible that later population movements into Europe, such as the arrival of farmers from Anatolia during the Neolithic period, diluted the Neanderthal genetic contribution. These new populations may have carried different genetic profiles that did not include the muscle-enhancing receptor. Over time, the variant became rarer in the European gene pool, effectively replaced by the genetic signatures of expanding agricultural societies. In South Asia, however, the population structure may have allowed the variant to thrive. The region's deep history of continuous settlement and large population sizes could have preserved rare genetic traits. The study highlights the importance of studying diverse populations to get a full picture of human genetic history. Focusing solely on European DNA misses crucial chapters of the human story that are written in the genes of Asian populations. This skewed distribution serves as a genetic map of our ancient past, tracing the footsteps of ancestors who navigated a prehistoric world.
Lab Cells Show 40% Growth Spike With Neanderthal Receptor
The study moved beyond observational data to prove the mechanism in a controlled environment. Scientists grew human cells in the laboratory and genetically engineered them to express the Neanderthal version of the growth hormone receptor. They then exposed these cells to human growth hormone to measure the response. The results were striking, providing a quantitative measure of the archaic gene's power. Cells with the Neanderthal receptor showed a 40% stronger response to the hormone compared to cells with the common modern human receptor. This significant increase demonstrates that the genetic changes alter the receptor's function at a molecular level. The receptor acts like a lock, and growth hormone is the key. The Neanderthal version of the lock turns more easily, opening the door to greater cellular growth. This heightened sensitivity means that for the same amount of circulating hormone, the body receives a stronger signal to build and repair tissue. Researchers identified two specific changes in the Neanderthal receptor that differ from the modern version, located at amino‑acid positions 345 and 378. They determined that one of these two changes is responsible for the vast majority of the increased sensitivity. This precision allows scientists to understand exactly which amino acids in the protein sequence drive the functional difference. It is a high-resolution look at evolution in action, showing how a single nucleotide change can ripple outward to affect phenotype. "The Neanderthal variant has two changes that are not present in the version most common in modern humans," the study authors wrote. These tiny mutations, involving just a few atoms in the DNA sequence, have a cascading effect on the entire organism. By boosting the signal from growth hormone, the variant encourages the body to allocate more resources to muscle tissue. This mechanism likely contributed to the robust skeletal structure and powerful musculature observed in Neanderthal fossil remains. The laboratory setting allowed the team to isolate the effect of the single gene. In a living human, muscle mass is influenced by diet, exercise, and dozens of other genes. By stripping away these variables, the researchers could confirm the direct impact of the Neanderthal DNA. The experiments were performed in triplicate across four independent cell lines, totaling twelve assays, ensuring robust statistical confidence. The 40% increase in cell growth provides a clear causal link between the archaic gene and the physical trait. This level of evidence is rare in the field of paleogenetics, where correlations are often the best data available. This experimental approach confirms that the differences are not merely correlations. The gene actively causes the change. The team used cell lines that are standard models for studying muscle physiology. This ensures the findings are reproducible and scientifically rigorous. The study bridges the gap between paleogenetics and molecular biology, showing that DNA extracted from ancient bones can have tangible effects in modern petri dishes. The discovery also raises questions about other Neanderthal genes. If this receptor has such a pronounced effect, other archaic variants might be influencing metabolism, brain function, or physical appearance in similar ways. The lab techniques used in this study provide a blueprint for testing those other genetic legacies.
Evolutionary Trade-Offs: Strength vs Energy Efficiency
Biology is rarely about free benefits. Every trait comes with a cost. While the Neanderthal receptor increases muscle mass, researchers point out that this advantage likely comes with significant metabolic trade‑offs. Muscle tissue is energetically expensive to maintain, requiring roughly 15% more calories at rest compared to leaner tissue. For Neanderthals living in the cold, high‑calorie diets rich in protein—estimated to provide about 30% of total calories—may have offset this cost, but for early modern humans facing periods of scarcity, carrying extra muscle could have been a liability. The concept of "thrifty" genotypes suggests that populations subjected to famine often evolve genetic profiles that promote fat storage and reduce energy expenditure. A receptor that drives muscle growth could be counter‑selected in environments where food is unpredictable. This may explain why the variant is not universally present. While it offers a strength advantage, it demands a higher caloric intake to fuel the increased muscle mass. In the brutal calculus of survival, being slightly weaker but more energy‑efficient might often win out over being stronger but hungrier. Furthermore, the growth hormone pathway is involved in numerous biological processes beyond muscle growth, including aging and metabolism. Altering the sensitivity of this receptor could potentially have downstream effects on longevity or insulin sensitivity. Some researchers speculate that the hyper‑efficient muscle growth might be linked to other Neanderthal traits that were eventually weeded out of the gene pool due to negative health consequences. This highlights the complexity of introgression; a gene that is beneficial in one context (Ice Age survival) might be neutral or even detrimental in another (agricultural society). The loss of this variant in European populations might reflect a shift toward agriculture. The Neolithic revolution brought with it a diet higher in carbohydrates and lower in animal protein compared to the Paleolithic. In this new dietary context, the caloric demands of a Neanderthal‑style muscular build may have become unsustainable. Individuals with the modern, less sensitive receptor might have been better able to survive on the available food supplies, leading to the gradual disappearance of the muscle‑boosting variant. This evolutionary trade‑off also provides insight into the health challenges faced by modern humans. Today, in an era of abundant food and sedentary lifestyles, the genetic propensity for muscle mass could be viewed as a benefit, potentially protecting against sarcopenia and obesity. However, for our ancestors, the equation was reversed. The study underscores that "fitness" in evolutionary terms is not about being the strongest or fastest, but about being the best adapted to a specific environment at a specific time. The Neanderthal gene variant is a testament to a lost world where brute strength was a prerequisite for survival.
Medical Implications: Treating Muscle Wasting and Aging
Beyond the historical narrative, the discovery of this hyper‑active growth hormone receptor variant holds promising implications for modern medicine. Muscle wasting conditions, such as sarcopenia (age‑related muscle loss), cachexia (wasting associated with chronic diseases like cancer), and muscular dystrophy, represent a massive burden on healthcare systems globally, affecting an estimated 50 million adults worldwide (industry reports indicate). Understanding how the Neanderthal variant boosts muscle growth could pave the way for novel therapeutic strategies. Current treatments for muscle wasting often involve synthetic growth hormone, which can have severe side effects because it affects the entire body, leading to issues like joint pain, insulin resistance, and carpal tunnel syndrome. The Neanderthal variant offers a more elegant solution. By mimicking the specific genetic mutation that makes the receptor more sensitive, pharmaceutical companies could develop drugs that amplify the body's natural response to growth hormone without introducing synthetic hormones. This could result in treatments that build muscle with fewer systemic side effects. "Understanding the functional impact of Neanderthal DNA helps us identify new targets for drug development," explains Zeberg. The 40% increase in cellular response observed in the lab is not trivial; it suggests that even a moderate pharmacological enhancement of receptor sensitivity could yield significant clinical benefits for patients struggling to maintain muscle mass. This is particularly relevant as the global population ages, and the prevalence of sarcopenia rises, reaching up to 20% in people over 60 years old. Moreover, this research could influence the field of gene therapy. If scientists can safely edit the GHR gene in muscle tissue to replicate the Neanderthal variant, it could offer a long‑term solution for genetic muscle disorders. While such applications are still in the theoretical or early research stages, the proof of concept provided by this study—that a single genetic change can have such a profound impact on muscle physiology—is a vital stepping stone. However, medical applications must be approached with caution. The evolutionary trade‑offs discussed earlier suggest that chronically elevated muscle growth signaling could have unintended consequences, such as an increased risk of cancer or metabolic disorders. Any therapeutic intervention based on this finding would need to be carefully tuned and targeted to avoid triggering the biological costs that caused the variant to become rare in the first place. The goal would not be to create Neanderthal‑like humans, but to borrow a specific tool from their genetic toolkit to treat specific modern ailments.
The Mosaic Genome: Contextualizing Archaic Introgression
The discovery of the muscle‑boosting variant is a single piece of a much larger puzzle regarding human evolution. It serves as a prime example of "archaic introgression"—the transfer of genetic material from one species (or subspecies) into the gene pool of another through hybridization. For decades, scientists viewed Neanderthal DNA as mostly junk or harmful, but recent research paints a picture of a complex genetic mosaic where archaic genes played a pivotal role in helping modern humans adapt to new environments. This specific finding is particularly noteworthy because it contrasts with the majority of known Neanderthal variants. Most identified Neanderthal genes are associated with traits like skin and hair structure, immune response, or susceptibility to diseases such as type 2 diabetes and Crohn's disease. Finding a variant that confers a positive physical attribute like increased muscle mass adds a new dimension to our understanding of this interbreeding. It suggests that the mating between modern humans and Neanderthals was not merely a fleeting encounter but a complex exchange of biological adaptations that helped *Homo sapiens* conquer diverse ecosystems across Eurasia. Comparisons with Denisovan DNA, another archaic hominin group, further illuminate this history. While Denisovan genes provided high‑altitude adaptations to about 2% of Tibetan populations, Neanderthal genes like the GHR variant appear to have provided physical robustness suited for the cold. This highlights a complementary relationship between the hominin groups; modern humans did not just replace their cousins, they absorbed and utilized the best genetic tools those cousins had evolved over hundreds of thousands of years. The study also forces a re‑evaluation of what it means to be "human." The binary distinction between "modern human" and "archaic" is increasingly blurred. We are, in a very literal sense, a hybrid species. The muscle‑boosting receptor is a living fossil within our cells, a molecular echo of a time when different hominin species walked the earth together. As sequencing technology improves and databases of ancient DNA grow, we are likely to discover even more of these archaic legacies. Over 100 Neanderthal‑derived variants have already been linked to phenotypic effects, and future research will likely focus on mapping the interactions between these archaic variants. How does the Neanderthal muscle gene interact with Neanderthal immune genes? Does the presence of one variant necessitate the presence of another? By untangling this web of genetic heritage, scientists hope to reconstruct the biology of our extinct relatives with unprecedented accuracy. The muscle mass study is just the beginning of a new era in evolutionary medicine, where the deep past informs the future of human health.